title: [First new oral anticoagulant with specific antidote].
authors.affiliation: .
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D000931:Antidotes / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control*; D000069604:Dabigatran / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D020521:Stroke / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000931:Antidotes; C000594745:idarucizumab; D000069604:Dabigatran